UMIN ID: UMIN000021352
Registered date:04/03/2016
A study for evaluating the effect of the intake of an indigestible dextrin-containing carbonated drink on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Healthy adult |
| Date of first enrollment | 2016/03/05 |
| Target sample size | 62 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | test carbonated drink with indigestible dextrin (single ingestion) - washout period - placebo carbonated drink without indigestible dextrin (single ingestion) placebo carbonated drink without indigestible dextrin (single ingestion) - washout period - test carbonated drink with indigestible dextrin (single ingestion) |
Outcome(s)
| Primary Outcome | area under the curve of plasma glucose |
|---|---|
| Secondary Outcome | Postprandial blood glucose, maximum plasma glucose level, insulin |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 64years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1) Subjects who routinely use food containing of indigestible dextrin (2) Subjects routinely taking medicine or health food which may influence glucose metabolism (3) Subjects who are under medication or having a history of serious diseases for which medication was required (4) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (5) Subjects having possibilities for emerging allergy related to the study (6) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (7) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (8) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (9) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (10) Subjects judged as unsuitable for the study by the investigator for other reasons |
Related Information
| Primary Sponsor | TTC Co.,Ltd. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Coca-Cola (Japan) Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyasu Shimada |
| Address | 1-20-2, Ebisunishi, Shibuya-ku, Tokyo Japan |
| Telephone | 03-5459-5329 |
| h.shimada@ttc-tokyo.co.jp | |
| Affiliation | TTC Co.,Ltd. Clinical Research Planning Department |
| scientific contact | |
| Name | Riko Fukuda |
| Address | Hibiya kokusai building B1F, 2-2-3, uchisaiwai-cho, Tokyo Japan |
| Telephone | 03-3503-3440 |
| kenshin@hibiyakokusai.or.jp | |
| Affiliation | Hibiya Kokusai Clinic Internal Medicine |